Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-17

Clinical Trial Update: An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease

View source ↗

Summary

An observational study evaluating OPTIVE PLUS for dry eye disease has completed and posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPTIVE PLUS

Snippet

Sponsor: Allergan | Conditions: Dry Eye Syndromes | Status: COMPLETED | Results posted: 2014-03-17